Nexara Health — Health Canada Drug Establishment Licence #3-002896

ALLEGRA 24 HOUR 120 MG

Last verified 2026-09-10 · Source: Health Canada Drug Product Database (DPD), DIN 02242819

ALLEGRA 24 HOUR 120 MG — DIN 02242819

FEXOFENADINE HYDROCHLORIDE : 120 MG · SANOFI CONSUMER HEALTH INC · TABLET · wholesale supply in Canada

Health Canada status: MARKETED

What is ALLEGRA 24 HOUR?

ALLEGRA 24 HOUR 120 MG contains FEXOFENADINE HYDROCHLORIDE : 120 MG. It is listed in the Health Canada Drug Product Database under DIN 02242819, held by SANOFI CONSUMER HEALTH INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 15-Nov-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ALLEGRA 24 HOUR used for?

ALLEGRA® (fexofenadine hydrochloride) is indicated for: the relief of symptoms associated with seasonal (ALLEGRA® 12 Hour, ALLEGRA® 24 Hour) and perennial (ALLEGRA® 12 Hour) allergic rhinitis, in adults and children 12 years of age and over. ALLEGRA® 12 Hour and ALLEGRA® HIVES are indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

How much does Fexofenadine cost around the world?

Fexofenadine is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Hungary publishes a producer price (ex-factory); South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Statesacquisition221USD███.██
South Africasingle exit price58ZAR███.██
Australiaex-manufacturer55AUD███.██
United Kingdomhospital22GBP███.██
Hungaryproducer price (ex-factory)11HUF███.██

37 pack listings across 15 brand entries and 5 price bases, refreshed 08 Sep 2026. Ranges span every Fexofenadine pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Fexofenadine in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

Only one market authorization holder has a Canadian DIN containing Fexofenadine — 3 DINs, of which 3 are currently marketed. There is no second Canadian source today, so a supply interruption on this holder has no domestic substitute at the same molecule.

Market authorization holderDINsMarketedBrand namesPosition
SANOFI CONSUMER HEALTH INC33ALLEGRA 12 HOUR, ALLEGRA 24 HOUR, ALLEGRA HIVESSourceable in Canada

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label120 MG
Dosage formTABLET
RouteORAL
Pack configuration (monograph)ALLEGRA® 12 Hour 60 mg tablets are available in blister packs of 36 tablets. ALLEGRA® 24 Hour 120 mg tablets are available in blister packs of 12, 30, 48, and 72 tablets. ALLEGRA® HIVES 60 mg tablets are available in blister packs of 36 tablets.
StorageRefer to section 11 STORAGE, STABILITY AND DISPOSAL for precise storage conditions.

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.

Substance and classification

Active substanceFexofenadine
ATC codeR06AX26
AHFS class24:32.04 ; 40:28.20
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02242819
DIN (unpadded, as printed on some documents)2242819
Brand nameALLEGRA 24 HOUR
Generic / active ingredientFEXOFENADINE HYDROCHLORIDE : 120 MG
Market authorization holderSANOFI CONSUMER HEALTH INC
Health Canada scheduleNON-PRESCRIPTION DRUGS
ATC codeR06AX26
ATC anatomical main groupR — Respiratory system
ATC therapeutic subgroupR06AX
Current statusMARKETED
Status date15-Nov-2019
Original market date2000-09-29 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

How is it administered?

Adults/Children 12+: 60 mg every 12 hours or 120 mg once daily with water. Renal impairment: start with 60 mg once daily. Do not take with fruit juices.

Included because it drives pack selection and wastage. Consult the monograph.

Contraindications

Known hypersensitivity to fexofenadine hydrochloride or to any ingredients in the formulation or component of the container.

Warnings and precautions

Do not take with fruit juices. Oral bioavailability may be reduced in patients with surgically manipulated or inflamed intestinal tissue. Potential for increased exposure in elderly/renal patients.

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

3 of 3 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
ALLEGRA 12 HOUR60 MGTABLETSANOFI CONSUMER HEALTH INCMARKETED02231462
ALLEGRA HIVES60 MGTABLETSANOFI CONSUMER HEALTH INCMARKETED02521245

2 · Same class — other molecules in ATC R06AX

MoleculeCanadian brandsDINsMarketedSourceable
Loratadine24 HOUR ALLERGY REMEDY · ALLERGY REMEDY · ALLERTIN · ALLERTIN TABLETS 10MG · +13 more2011Yes
BilastineAURO-BILASTINE · BLEXTEN · GLN-BILASTINE · JAMP BILASTINE · +4 more1010Yes
RupatadineAPO-RUPATADINE · PMS-RUPATADINE · RIVA-RUPATADINE · RUPALL55Yes
DesloratadineAERIUS · AERIUS KIDS · ALLERGY CONTROL DESLORATADINE · ALLERNIX MULTI SYMPTOM · +3 more94Yes
CyproheptadineEURO-CYPROHEPTADINE 2MG/5ML · EURO-CYPROHEPTADINE 4 MG/TABLET · JAMP CYPROHEPTADINE SYRUP · JAMP-CYPROHEPTADINE · +6 more103Yes
FexofenadineALLEGRA 12 HOUR · ALLEGRA 24 HOUR · ALLEGRA HIVES33Yes
KetotifenAPO-KETOTIFEN - SYR 1MG/5ML · NOVO-KETOTIFEN - SYR 1MG/5ML · NOVO-KETOTIFEN TAB 1MG · NU-KETOTIFEN SYRUP - 1MG/5ML · +3 more91Yes
Other Antihistamines For Systemic UseAPO-BILASTINE ORAL SOLUTION · APO-BILASTINE ORODISPERSIBLE TABLETS · APO-BILASTINE TABLETS31Yes
TerfenadineALLERGY RELIEF · APO-TERFENADINE TAB 120MG · APO-TERFENADINE TABLETS 60MG · NOVO-TERFENADINE TAB 60MG · +7 more110Not in Canada
AstemizoleHISMANAL - TAB 10MG · HISMANAL SUSPENSION 2MG/ML · HISMANAL TAB 10MG30Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC R06A

ATC subgroupMoleculesDINsMarketed
R06AAClemastine · Dimenhydrinate · Dimenhydrinate, Combinations · Diphenhydramine · Diphenhydramine, Combinations · +3 more26476
R06AECetirizine · Cyclizine · Meclozine · Meclozine, Combinations6927
R06ABBrompheniramine · Chlorpheniramine · Dexchlorpheniramine171
R06ADAlimemazine · Promethazine171
R06ACTripelennamine10

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is ALLEGRA 24 HOUR called?

The same molecule, Fexofenadine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
TelfastLatinAustralia
XergicLatinAustralia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ALLEGRA 24 HOUR

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Related pages

Sourcing this product